Learning from remote decentralised clinical trial experiences: A qualitative analysis of interviews with trial personnel, patient representatives and other stakeholders
Open Access
- 12 August 2021
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 88 (3), 1031-1042
- https://doi.org/10.1111/bcp.15003
Abstract
Aims The aim of the study was to identify actionable learning points from stakeholders in remote decentralised clinical trials (RDCTs) to inform their future design and conduct. Methods Semi-structured interviews were carried out with a purposive sample of stakeholders, including senior managers, trial managers, technology experts, principal investigators, clinical investigators, research scientists, research nurses, vendors, patient representatives, and project assistants. The interview data were coded using a thematic approach, identifying similarities, differences, and clustering to generate descriptive themes. Further refinement of themes was guided by empirical phenomenology, grounding explanation in the meanings that interviewees gave to their experiences. Results 48 stakeholders were interviewed. Actionable learning points were generated from the thematic analysis. Patient involvement and participant engagement were seen as critical to the success of RDCTs where in-person contact is minimal or non-existent. Involving patients in identifying the research question, creating recruitment materials, apps and websites, and providing ongoing feedback to trial participants, were regarded as facilitating recruitment and engagement. Building strong relationships early with trial partners was thought to support RDCT conduct. Multiple modes of capturing information, including patient-reported outcomes (PROs) and routinely collected data, were felt to contribute to data completeness. However, RDCTs may transfer trial activity burden onto participants and remote-working research staff; therefore, additional support may be needed. Conclusion RDCTs will continue to face challenges in implementing novel technologies. However, maximising patient and partner involvement, reducing participant and staff burden, and simplifying how participants and staff interact with the RDCT may facilitate their implementation.Funding Information
- Innovative Medicines Initiative (831458)
This publication has 26 references indexed in Scilit:
- Use of mobile devices and the internet for multimedia informed consent delivery and data entry in a pediatric asthma trial: Study design and rationaleContemporary Clinical Trials, 2015
- Web-based trial to evaluate the efficacy and safety of tolterodine ER 4mg in participants with overactive bladder: REMOTE trialContemporary Clinical Trials, 2014
- The Interview: Data Collection in Descriptive Phenomenological Human Scientific ResearchJournal of Phenomenological Psychology, 2012
- Strategies to improve recruitment to randomised controlled trialsEmergencias, 2010
- Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groupsInternational Journal for Quality in Health Care, 2007
- Using thematic analysis in psychologyQualitative Research in Psychology, 2006
- Barriers to Participation in Randomised Controlled Trials: A Systematic ReviewJournal of Clinical Epidemiology, 1999
- Sampling in qualitative research. Purposeful and theoretical sampling; merging or clear boundaries?Journal of Advanced Nursing, 1997
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyThe New England Journal of Medicine, 1989
- Randomised trial of prophylactic daily aspirin in British male doctorsBMJ, 1988